Hovik, Norway

Bjørn S Skålhegg

This inventor holds 1 USPTO granted patent. Top assignee: Lauras as. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bjørn S Skålhegg. Retrieved from https://idiyas.com/inventor/bjørn-s-skålhegg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Bjørn S Skålhegg

Introduction

Bjørn S Skålhegg is a notable inventor based in Høvik, Norway. He has made significant contributions to the field of pharmaceuticals, particularly in the area of immunomodulation. His work focuses on developing compositions that can effectively treat immunosuppressive diseases.

Latest Patents

Bjørn S Skålhegg holds a patent for the use of immunomodulating agents. This patent describes pharmaceutical compositions that are useful for treating immunosuppressive diseases. The compositions contain compounds capable of inhibiting cAMP-dependent protein kinase A (PKA), which plays a crucial role in various cellular processes.

Career Highlights

Throughout his career, Bjørn has demonstrated a commitment to advancing medical science. His innovative approaches have led to the development of new therapeutic options for patients suffering from immunosuppressive conditions. His work is recognized for its potential impact on healthcare.

Collaborations

Bjørn has collaborated with esteemed colleagues such as Kjetil Taskén and Einar Martin Aandahl. These partnerships have fostered a collaborative environment that enhances research and development in their field.

Conclusion

Bjørn S Skålhegg is a distinguished inventor whose work in immunomodulating agents has the potential to transform treatment options for immunosuppressive diseases. His contributions to pharmaceutical science are invaluable and continue to inspire future innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…